NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 119 filers reported holding NURIX THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $692,199 | +24.1% | 88,066 | +57.7% | 0.02% | +13.3% |
| Q2 2023 | $557,981 | +80.8% | 55,854 | +60.7% | 0.02% | +87.5% |
| Q1 2023 | $308,553 | +3.9% | 34,747 | +28.5% | 0.01% | 0.0% |
| Q4 2022 | $297,009 | -8.9% | 27,050 | +8.3% | 0.01% | -27.3% |
| Q3 2022 | $326,000 | +148.9% | 24,986 | +141.4% | 0.01% | +83.3% |
| Q2 2022 | $131,000 | -78.9% | 10,350 | -76.7% | 0.01% | -79.3% |
| Q1 2022 | $621,000 | +9.3% | 44,328 | +125.8% | 0.03% | -17.1% |
| Q4 2021 | $568,000 | +47.9% | 19,632 | +59.1% | 0.04% | 0.0% |
| Q1 2021 | $384,000 | – | 12,337 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 4,508,333 | $140,164,000 | 17.73% |
| Ponoi II Management, LLC | 686,274 | $21,336,000 | 16.34% |
| Column Group LLC | 5,383,333 | $167,368,000 | 16.04% |
| Ponoi Management, LLC | 686,274 | $21,336,000 | 12.55% |
| Foresite Capital Management IV, LLC | 1,238,456 | $38,504,000 | 4.61% |
| Foresite Capital Management V, LLC | 451,522 | $14,038,000 | 4.13% |
| WestHill Financial Advisors, Inc. | 283,333 | $8,809,000 | 3.13% |
| EcoR1 Capital, LLC | 2,019,019 | $62,771,000 | 2.78% |
| Bain Capital Life Sciences Investors, LLC | 1,284,314 | $39,929,000 | 2.26% |
| DAFNA Capital Management LLC | 306,320 | $9,523,000 | 2.26% |